Does Vitamin D3 level improves in a person suffering from Manyasthambha(Cervical spondylosis) by taking internal medication.

Comparative study of Panchatikta ghrta with Vitamin D3 and Vitamin D3 in the Management of Manyasthambha(Cervical spondylosis) w.s.r to Vitamin D3 deficiency - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/069836

Enrollment

Registered

2024-07-02

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M479- Spondylosis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient willing to participate in this trial through written informed consent. 2.Patients with presenting symptoms of cervical spondylosis. 3.Clinical symptoms with or without radiological changes 4.Vitamin D3 Deficiency.

Exclusion criteria

Exclusion criteria: 1.Patients below 18yrs and above 70yrs of age. 2.Vitamin D3 Insufficiency.

Design outcomes

Primary

Measure	Time frame
Improvement in clinical symptoms-parameters such as Pain, Stiffness, Tingling numbness, Lateral movement, Extension and Flexion of Neck and Vitamin D3 Deficiency after 28days of Administration of Internal medication.Timepoint: 35days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Dnyaneshwar M Padavi

Padmashree Dr D Y Patil School of Ayurveda,Nerul,Thane,Navi Mumbai

dmpadavi@gmail.com9833158688

Outcome results